SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain

Sodium glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like-peptide-1 receptor (GLP-1-R) agonists are novel therapeutic agents used for the management of type 2 diabetes mellitus (T2DM). Recently, large-scale randomized clinical trials have been conducted to assess the cardiovascular safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolek, Bartosz, Haber, Mateusz, Gajewska, Magdalena, Rogula, Sylwester, Pietrasik, Arkadiusz, Gąsecka, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455499/
https://www.ncbi.nlm.nih.gov/pubmed/37623335
http://dx.doi.org/10.3390/jcdd10080322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455499/
https://www.ncbi.nlm.nih.gov/pubmed/37623335
http://dx.doi.org/10.3390/jcdd10080322

Ejemplares similares